Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates (Q45889555)
Jump to navigation
Jump to search
scientific article published in December 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates |
scientific article published in December 2005 |
Statements
1 reference
Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates (English)
1 reference
1 reference
Neil R Hackett
1 reference
D Eugene Redmond
1 reference
Dolan Sondhi
1 reference
E Lela Giannaris
1 reference
Elizabeth Vassallo
1 reference
Jamie Stratton
1 reference
Jianping Qiu
1 reference
Martin L Lesser
1 reference
Gene S Fisch
1 reference
Serge D Rouselle
1 reference
Ronald G Crystal
1 reference
1 December 2005
1 reference
1 reference
16
1 reference
1484-1503
1 reference
12
1 reference
Identifiers
1 reference
1 reference